Form 3 Filing: Carolyn S. Starrett Reports No Securities Ownership in Neogenomics Inc.

This is a Form 3 filing by Carolyn S. Starrett, a director of Neogenomics Inc. (NEO), filed on June 25, 2026, with a reporting period of June 23, 2026. The filing indicates that Ms. Starrett reports no securities ownership in the company. As a director, she is required to file this initial statement of beneficial ownership under Section 16 of the Securities Exchange Act of 1934. The filing shows she is based in Fort Myers, Florida, and serves as a director of the company. The document appears to be incomplete or corrupted in the text section, but the structured data shows no derivative or non-derivative securities holdings reported.